Novavax Stock Forecast 2024. Novavax narrowed its losses in the. Novavax ( nvax 9.46%) has given investors a bumpy ride this year.
Why nvax stock could 12x in the next 12 months. Novavax is a sell for sa analysts, including stephen ayers, who issued a strong sell on the stock this week, citing significant hurdles the company has to face in 2024.
According To Our Technical Indicators, The Current Sentiment Is Bearish While The Fear &Amp; Greed Index Is Showing 39 (Fear).
Novavax misses quarterly estimates, but vaccine maker narrows losses as it slashes costs.
Cantor Fitzgerald Lowered Their Price Target On Shares Of Novavax From $282.00 To $174.00 And Set An “Overweight” Rating On The Stock In A Report On Monday, February 14Th.
Why nvax stock could 12x in the next 12 months.
This Implies A Chunky 15% Decline In Revenue Compared To The Last 12.
According to our current nvax stock forecast, the value of novavax shares will rise by 5.82% and reach $ 5.23 per share by march 6, 2024.
Images References :
Nvax Will Report Q1 Earnings On 05/07/2024.
This implies a chunky 15% decline in revenue compared to the last 12.
Novavax Is A Sell For Sa Analysts, Including Stephen Ayers, Who Issued A Strong Sell On The Stock This Week, Citing Significant Hurdles The Company Has To Face In 2024.
Novavax ( nvax) is a sell for sa analysts, including stephen ayers, who issued a strong sell on the stock this week, citing significant hurdles the company has to face in 2024.